XML 69 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Details) - Forecast
$ in Millions
1 Months Ended
Nov. 30, 2022
USD ($)
Cybrexa Therapeutics, LLC (Cybrexa)  
Subsequent Event [Line Items]  
Collaborative arrangement, upfront payment $ 60.0
Collaborative arrangement, maximum aggregate development milestone payments 65.0
Maximum amount of warrant to be exercised 300.0
Additional development regulatory and commercial milestones payments 277.5
Sairopa, B.V. (Sairopa)  
Subsequent Event [Line Items]  
Collaborative arrangement, upfront payment 40.0
Collaborative arrangement, maximum aggregate development milestone payments 97.5
Additional development regulatory and commercial milestones payments 465.0
Option to exercise, amount $ 225.0